65,437 trials
Clostridium Difficile Associated Disease
Primary: Adjusted Geometric Mean Concentration (GMC) of Clostridium Difficile Toxin A and Toxin B Specific Neutralizing Antibodies at Month 7 for Evaluable Immunogenicity…
Knowledge · Attitude to Health · Practice
Primary: Effect of Oral Health Education on the Oral Health Knowledge in Primary School Children Aged 7-9 Years Old — 2.71; 0.81 knowledge score on a scale
Phenylketonuria
Primary: Part 2 Double-blind Phase: Mean Change From Baseline in Blood Phenylketonuria (Phe) Level to Weeks 5 and 6 (Averaged Over a 2-week Period) in Participants With Phe…
Biliary Atresia
Primary: Number of Patients With Biliary Atresia (BA) Achieving Total Serum Bile Acids Less Than or Equal to 10 *U*Mol/L Within 24 Weeks of Kasai Portoenterostomy (KP) — 0…
Blood Donors
Primary: Donation Attempt — 2; 2; 2; 7 Participants — p=0.23
Premature Infant · Extremely Low Birth Weight · Extreme Prematurity
Primary: Time to Heart Rate Display in iRes Warmer With Resusview — 16; 50 seconds from time of birth
Melanoma
Primary: Number of Conversions of Non-inflamed to Inflamed Melanoma — 3; 7 Participants
Presbyopia
Primary: Overall Vision Satisfaction — 78.6; 83.5 score on a scale
Alzheimer Disease · Dementia · Sleep Disorder
Primary: Sleep (Actigraph Measurement) — 544.00 Nighttime sleep minutes
Migraine · Headache · Multiple Sclerosis
Primary: Number of Patients Enrolled in the Study — 24; 24 Participants
Brain Death · Heart Failure
Primary: Heart Transplanted — 230; 223 Participants — p=0.57
Cerebral Palsy
Primary: The Metabolic Energy Required to Walk — 2.42; -2.14 % change pre vs post gait training — p=0.204
Epithelial Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer
Primary: Phase 2: Progression Free Survival (PFS), as Determined by the Local Investigator Using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) — 1.51…
Myelofibrosis · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Primary: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
Myopia · Hyperopia
Primary: Subjective Overall Score — 84.7; 82.5 score on a scale